Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 845-856

  Wang, Guangshun ^a   Epand, Raquel F ^b   Mishra, Biswajit ^a   Lushnikova, Tamara ^a   Thomas, Vinai Chittezham ^a   Bayles, Kenneth W ^a   Epand, Richard M ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; LYSINE;

ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOENGINEERING; CELL VACUOLE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; MEMBRANE DAMAGE; MUTATION; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CATIONS; ESCHERICHIA COLI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUTATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84862968750     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05637-11     Document Type: Article

References (66)

1. Ames BN. 1966. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8:115-118.
2. Bax A, Davis DG. 1985. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:355-360.
3. Blondelle SE, Houghten RA. 1992. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry (N.Y.) 31:12688-12694. (Pubitemid 23016537)
4. Boman HG. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:61-92.
5. Braff MH, et al. 2005. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174:4271-4278. (Pubitemid 40396008)
6. Cierpicki T, Otlewski J. 2001. Amide proton temperature coefficients as hydrogen bond indicators in proteins. J. Biomol. NMR 21:249-261. (Pubitemid 33133425)
7. Clore GM, Gronenborn AM. 1998. Determining the structures of large proteins and protein complexes by NMR. Trends Biotechnol. 16:22-34. (Pubitemid 28064815)
8. Cornilescu G, Delaglio F, Bax A. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13:289-302. (Pubitemid 29143535)
9. Dathe M, Wieprecht T. 1999. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462:71-87.
10. Delaglio F, et al. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6:277-293.
11. Epand RM, Vogel HJ. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
12. Epand RF, Wang G, Berno B, Epand RM. 2009. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37. Antimicrob. Agents Chemother. 53:3705-3714.
13. Epand RM, et al. 2010. Lipid clustering by three homologous argininerich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure. Biochim. Biophys. Acta 1798:1272-1280.
14. Epand RM, Epand RF. 2010. Biophysical analysis of membrane targeting antimicrobial peptides: membrane properties and design of peptides specifically targeting Gram-negative bacteria, p 116-127. In Wang G (ed), Antimicrobial peptides: discovery, design and novel therapeutic strategies. CABI, Wallingford, Oxfordshire, England.
15. Ericksen B, Wu Z, Lu W, Lehrer RI. 2005. Antibacterial activity and specificity of the six human α-defensins. Antimicrob. Agents Chemother. 49:269-275. (Pubitemid 40065802)
16. Ferre R, et al. 2009. Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100. Biophys. J. 96:1815-1827.
17. Garrett DS, Powers R, Gronenborn AM, Clore GM. 1991. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. J. Magn. Reson. 95:214-220.
18. Hancock RE, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557. (Pubitemid 44967479)
19. Haney EF, Hunter HN, Matsuzaki K, Vogel HJ. 2009. Solution NMR studies of amphibian antimicrobial peptides: linking structure to function? Biochim. Biophys. Acta 1788:1639-1655.
20. Jeener J, Meier BH, Bachmann P, Ernst RR. 1979. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71:4546-4553.
21. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273:3718-3724. (Pubitemid 28109800)
22. Kay LE, Keifer P, Saarinen T. 1992. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114:10663-10665.
23. Kim YS, Cha HJ. 2010. Disperse distribution of cationic amino acids on hydrophilic surface of helical wheel enhances antimicrobial peptide activity. Biotechnol. Bioeng. 107:216-223.
24. Koradi R, Billeter M, Wüthrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55. (Pubitemid 26152976)
25. Ladokhin AS, Wimley WC, White SH. 1995. Leakage of membrane vesicle contents: determination of mechanism using fluorescence requenching. Biophys. J. 69:1964-1971.
26. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8:477-486. (Pubitemid 126706801)
27. Lee M, Hung W, Chen F, Huang HW. 2008. Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides. Proc. Natl. Acad. Sci. U. S. A. 105:5087-5092. (Pubitemid 351738514)
28. Lee PHA, et al. 2005. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. U. S. A. 102:3750-3755. (Pubitemid 40354683)
29. Lehrer RI, Barton A, Ganz T. 1988. Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis activity in E. coli by multiple-wavelength spectroscopy. J. Immunol. Methods 108:153-158.
30. Lehrer RI, et al. 1989. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84:553-561. (Pubitemid 19196987)
31. Li X, Li Y, Han H, Miller DW, Wang G. 2006. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 128:5776-5785. (Pubitemid 43724381)
32. Liu PT, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
33. Loit E, Hincke MT, Altosaar I. 2010. Synthetic antimicrobial peptide L8 (MHLHKTSRVTLYLL) has membrane permeabilisation and bacterial aggregation activity. Int. J. Antimicrob. Agents 35:410-416.
34. Ludtke SJ, et al. 1996. Membrane pores induced by magainin. Biochemistry 35:13723-13728. (Pubitemid 26363914)
35. Markley JL, et al. 1998. Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy. J. Biomol. NMR 12:1-23. (Pubitemid 128512831)
36. Matsuzaki K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462:1-10.
37. Nell MJ, et al. 2006. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27:649-660.
38. Neville F, et al. 2006. Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys. J. 90:1275-1287.
39. Nijnik A, Hancock REW. 2009. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol. 16:41-47.
40. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. 1999. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341:501-513. (Pubitemid 29389178)
41. Papo N, Shai Y. 2003. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 24:1693-1703. (Pubitemid 38198076)
42. Putsep K, Carlsson G, Boman HG, Andersson M. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149. (Pubitemid 35246490)
43. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117:479-485.
44. Rothbard JB, Jessop TC, Lewis RS, Murray BA, Wender PA. 2004. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126:9506-9507. (Pubitemid 39031015)
45. Sakai N, Matile S. 2003. Anion-mediated transfer of polyarginine across liquid and bilayer membranes. J. Am. Chem. Soc. 125:14348-14356. (Pubitemid 37452373)
46. Sambhara S, Lehrer RI. 2007. The innate immune system: a repository for future drugs? Expert Rev. Anti Infect. Ther. 5:1-5. (Pubitemid 46605095)
47. Sarig H, et al. 2010. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24:1904-1913.
48. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. 2003. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160:65-73.
49. Shai Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
50. Sieprawska-Lupa M, et al. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679. (Pubitemid 39577671)
51. Sigurdardottir T, et al. 2006. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob. Agents Chemother. 50:2983-2989. (Pubitemid 44396402)
52. Sochacki KA, Barns KJ, Bucki R, Weisshaar JC. 2011. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc. Natl. Acad. Sci. U. S. A. 108:77-81.
53. Tossi A, Sandri L, Giangaspero A. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
54. Wang G. 2006. Structural biology of antimicrobial peptides by NMR spectroscopy. Curr. Org. Chem. 10:569-581.
55. Wang G. 2007. Determination of solution structure and lipid micelle location of an engineered membrane peptide by using one NMR experiment and one sample. Biochim. Biophys. Acta 1768:3271-3281. (Pubitemid 350236078)
56. Wang G. 2008. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 283:32637-32643.
57. Wang G. 2010. Structural studies of antimicrobial peptides provide insight into their mechanisms of action, p 141-168. In Wang G (ed), Antimicrobial peptides: discovery, design and novel therapeutic strategies. CABI, Wallingford, Oxfordshire, England.
58. Wang G, Li X, Wang Z. 2009. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 37:D933-D937.
59. Wang G, Li Y, Li X. 2005. Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J. Biol. Chem. 280:5803-5811. (Pubitemid 40280061)
60. Wang Z, Wang G. 2004. APD: the Antimicrobial Peptide Database. Nucleic Acids Res. 32:D590-D592. (Pubitemid 38081727)
61. White JH, Bitton AJ. 2010. Role of vitamin D in the enhancement of antimicrobial peptide gene expression, p 181-194. In Wang G (ed), Antimicrobial peptides: discovery, design and novel therapeutic strategies. CABI, Wallingford, Oxfordshire, England.
62. Wüthrich K. 1986. NMR of proteins and nucleic acids. Wiley, New York, NY.
63. Yan H, Li S, Sun X, Mi H, He B. 2003. Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. FEBS Lett. 554:100-104. (Pubitemid 37324822)
64. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. (Pubitemid 34100944)
65. Zhang X, et al. 2010. Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. Biochim. Biophys. Acta 1798:2201-2208.
66. Zou G, et al. 2007. Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J. Biol. Chem. 282:19653-19665. (Pubitemid 47100066)